1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 31 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2018A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at RiskRedondo, M.J.; Geyer, S.; Steck, A.K.; Sharp, S.; Wentworth, J.M.; Weedon, M.N.; Antinozzi, P.; Sosenko, J.; Atkinson, M.; Pugliese, A.; Oram, R.A.; Type 1 Diabetes TrialNet Study Group,
2012The influence of circadian time and sleep dose on subjective fatigue ratingsFerguson, S.; Paech, G.; Sargent, C.; Darwent, D.; Kennaway, D.; Roach, G.
2012A comparison of two different continuous theta burst stimulation paradigms applied to the human primary motor cortexGoldsworthy, M.; Pitcher, J.; Ridding, M.
2014The influence of a single bout of aerobic exercise on short-interval intracortical excitabilitySmith, A.; Goldsworthy, M.; Garside, T.; Wood, F.; Ridding, M.
2010Hypomorphic temperature-sensitive alleles of NSDHL cause CK syndromeGecz, J.
2011Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12)Isbister, G.; White, J.; Currie, B.; O'Leary, M.; Brown, S.
2013Parental perspectives of vaccine safety and experience of adverse events following immunisationParrella, A.; Gold, M.; Marshall, H.; Braunack-Mayer, A.; Baghurst, P.
2014Community, parental and adolescent awareness and knowledge of meningococcal diseaseWang, B.; Clarke, M.; Hajiali Afzali, H.; Marshall, H.
2012Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialRichmond, P.; Marshall, H.; Nissen, M.; Jiang, Q.; Jansen, K.; Garces-Sanchez, M.; Martinon-Torres, F.; Beeslaar, J.; Szenborn, L.; Wysocki, J.; Eiden, J.; Harris, S.; Jones, T.; Perez, J.
2012A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trialRichmond, P.; Nissen, M.; Marshall, H.; Lambert, S.; Roberton, D.; Gruber, W.; Jones, T.; Arora, A.

Discover